In a lawsuit filed yesterday, MIT and Children's Hospital charge Shire Regenerative Medicine's product aimed at people with diabetic foot ulcers violates patents they hold for building skin grafts on a polyester matrix.
The two local institutions say Shire's Dermagraft , in which cells from newborn foreskins are laid on a thin membrane to grow a layer of skin that are then applied atop the ulcers that some diabetic patients develop on their feet.
They're seeking tons of money for the injuries the alleged patent infrigement has done them.
One of the patents .
|Complaint by MIT and Children's Hospital ||48.31 KB|